Objectives: Plasma medicine focuses on the application of cold atmospheric pressure plasmas (CAPs) in or on the human body. So far, plasmas have been used to sterilize implant materials or other thermally unstable medical products and have been applied for chemical surface modifications. This study investigates the antimicrobial effect of physical plasmas on microorganisms which cause skin infections, such as Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans, depending on the plasma source and the kind of plasma excitation used. Materials: Microorganisms were plated onto MH2 agar plates. Plasma treatment was performed using the plasma sources BLASTER MEF and kinpen 09. To investigate the antimicrobial effects, the following plasma parameters have been varied: working gas, distance from nozzle to surface, electrical power, grid spacing of treatment lines, number of treatments and work piece velocity. Results: The generated plasmas had an antimicrobial effect that depended on the chosen plasma parameters, in particular on the process gas used, the plasma power and the number of treatments performed. Thus, different reactive species were observed by optical emission spectroscopy measurement in the generated plasmas. Conclusions: The study showed that CAPs exhibit profound bactericidal and fungicidal properties in vitro. However, an important factor for the antimicrobial efficacy is the composition of the ‘chemical soup' supplied by the CAP system which can be regulated by the process gases used.

Keywords:
Antimicrobial treatment, Bacteria, Cold atmospheric pressure plasma, Yeast
1.
Kong MG, Kroesen G, Morfill G, Nosenko T, Shimizu T, van Dijk J, Zimmermann JL: Plasma medicine: an introductory review. New J Phys 2009;11:115012.
2.
Zimmermann JL, Shimizu T, Schmidt H-U, Li Y-F, Morfill GE, Isbary G: Test for bacterial resistance build-up against plasma treatment. New J Phys 2012;14:073037.
3.
Falanga V: Classifications for wound preparation and stimulation of chronic wounds. Wound Repair Regen 2000;8:347-352.
4.
Sibbald GR, Orsted H, Schultz GS, Coutts P, Keast D: Preparing the wound bed: focus on infection and inflammation. Ostomy Wound Manage 2003;49:24-51.
5.
Warriner R, Burrel RE: Infection and the chronic wound: a focus on silver. Adv Skin Wound Care 2005;18:2-12.
6.
Wright JB; Lam K; Buret AG; Olson ME; Burrell RE: Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen 2002;10:141-151.
7.
Dissemond J, Schmid EN, Esser S, Witthoff M, Goos M: Bakterielle Kolonisation chronischer Wunden. Hautarzt 2004;55:280-288.
8.
Bowler PG, Suerden BI, Armstrong DG: Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001;14:244-269.
9.
White RJ, Cutting K, Kingsley A: Topical antimicrobials in the control of wound bioburden. Ostomy Wound Manage 2006;52:26-58.
10.
McDonnel G, Russel AD: Antiseptics and disinfectants: activity, action and resistance. Clin Microbiol Rev 1999:12:147-179.
11.
Wiegand C, Heinze T, Hipler U-C: Comparative in vitro study on cytotoxicity, antimicrobial activity, and binding capacity for pathophysiological factors in chronic wounds of alginate and silver-containing alginate. Wound Repair Regen 2009;17:511-521.
12.
Ip M, Lui SL, Poon VKM, Lung I, Burd A: Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol 2006;55:59-63.
13.
Hidalgo E, Bartolome R, Barroso C, Moreno A, Dominguez C: Silver nitrate: antimicrobial activity related to cytotoxicity in cultured human fibroblasts. Skin Pharmacol Appl Skin Physiol 1998;11:140-151.
14.
Moisan M, Barbeau J, Moreau S, Pelletier J, Tabrizian M, Yahia LH: Low-temperature sterilization using gas plasmas: a review of the experiments and an analysis of the inactivation mechanisms. Int J Pharm 2001;226:1-21.
15.
Lloyd G, Friedman G, Jafri S, Schultz G, Fridman A, Harding K: Gas plasma: medical uses and developments in wound care. Plasma Process Polym 2010;7:194-211.
16.
Rauscher H; Kylian O; Benedikt J, von Keudell A, Rossi F: Elimination of biological contaminations from surfaces by plasma discharges: chemical sputtering. Chem Phys Chem 2010;11:1382-1389.
17.
von Keudell A, Awakowicz P, Benedikt J; Raballand V, Yanguas-Gil A, Opretzka J, Flötgen C, Reuter R, Byelykh L, Halfmann H, Stapelmann K, Denis B, Wunderlich J, Muranyi P, Rossi F, Kylian O, Hasiwa N, Ruiz A, Rauscher H, Sirghi L, Comoy E, Dehen C, Challier L, Deslys JP: Inactivation of bacteria and biomolecules by low-pressure plasma discharges. Plasma Process Polym 2010;7:327-352.
18.
Stoffels E, Sakiyama Y, Graves B: Cold atmospheric plasma: charged species and their interactions with cells and tissues. IEEE Trans Plasma Sci 2008;36:1441-1457.
19.
Boudam MK, Moisan M, Saoudi B, Popodivici C, Gherardi N, Massines F: Bacterial spore inactivation by atmospheric-pressure plasmas in the presence or absence of UV photons as obtained with the same gas mixture. J Phys D Appl Phys 2006;39:3494-3507.
20.
Isbary G, Heinlin J, Shimizu T, Zimmermann JL, Morfill G, Schmidt HU, Monetti R, Steffes B, Bunk W, Li Y, Klaempfl T, Karer S, Landthaler M, Stolz W: Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds results of a randomized controlled trial. Br J Dermatol 2012;167:404-410.
21.
Heinlin J, Morfill G, Landthaler M, Stolz W, Isbary G, Zimmermann JL, Shimizu T, Karrer S: Plasma medicine: possible applications in dermatology. J Dtsch Dermatol Ges 2010;8:968-977.
22.
Neoplas GmbH: ‘Kinpen 09' datasheet. http://www.inp-greifswald.de/web-n.nsf/0/3A43E4847E20DB6DC12578FF003E8876/$File/kinpen_ger.pdf (accessed October 2012).
23.
TIGRES Dr. Gerstenberg GmbH. http://www.tigres.de/image/tigres-publikation_50_potenzialfreies_atmosphrenplasma_in.pdf (accessed September 2012).
24.
TIGRES Dr. Gerstenberg GmbH. http://www.tigres.de/image/tigres-produkte_plasma-blaster-st362.pdf (accessed September 2012).
25.
Beier O, Pfuch A, Horn K, Weisser J, Schnabelrauch M, Schimanski A: Low temperature deposition of antibacterially active silicon oxide layers containing silver nanoparticles, prepared by atmospheric pressure plasma chemical vapor deposition. Plasma Process Polym 2013;10:1:77-87.
26.
Horn K, Schütte T, Struppert T, Beier O, Tölke T, Eckardt N, Schimanski A, Grünler B: Spectroscopic Plasma Monitoring Deploying Quality and Process Control to Atmospheric Pressure Plasma Application; Suchentrunk R (ed). Bad Saulgau, Leuze, Jahrbuch Oberflächentechnik 2012, vol 68, pp 85-97.
27.
Daeschlein G, von Woedtke T, Kindel E, Brandenburg R, Weltmann KD, Jünger M: Antibacterial activity of an atmospheric pressure plasma jet against relevant wound pathogens in vitro on a simulated wound environment. Plasma Process Polym 2010;7:224-230.
28.
Lommatzsch U, Pasedag D, Baalmann A, Ellinghorst G, Wagner HE: Atmospheric pressure plasma jet treatment of polyethylene surfaces for adhesion improvement. Plasma Process Polym 2007;4:1041-1045.
29.
Daeschlein G, Scholz S, Ahmedb R, von Woedtke T, Haasea H, Niggemeier M, Kindel E, Brandenburg R, Weltmann K-D, Juenger M: Skin decontamination by low-temperature atmospheric pressure plasma jet and dielectric barrier discharge plasma. J Hosp Infect 2012;81:177-183.
30.
Isbary G, Morfill G, Schmidt HU, Georgi M, Ramrath K, Heinlin J, Karrer S, Landthaler M, Shimizu T, Steffes B, Bunk W, Monetti R, Zimmermann JL, Pompl R, Stolz W: A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. J Br Dermatol 2010;163:78-82.
31.
Goree J, Liu B, Drake D: Gas flow dependence for plasma-needle disinfection of S. mutans bacteria. J Phys D Appl Phys 2006;39:3479-3486.
32.
Hähnel M, von Woedtke T, Weltmann KD: Influence of the air humidity on the reduction of Bacillus spores in a defined environment at atmospheric pressure using a dielectric barrier surface discharge. Plasma Process Polym 2010;7:244-249.
33.
Dobrynin D, Fridman G, Friedman G, Fridman A: Physical and biological mechanisms of direct plasma interaction with living tissue. New J Phys 2009;11:115020.
34.
Schneider S, Lackman J-W, Ellerweg D, Denis B, Narberhaus F, Bandow JE, Benedikt J: The role of VUV radiation in the inactivation of bacteria with an atmospheric pressure plasma jet. Plasma Process Polym 2012;9:561-568.
35.
Nosenko T, Shimizu T, Morfill GE: Designing plasmas for chronic wound disinfection. New J Phys 2009;11:115013.
36.
Sarrette J-P, Cousty S, Clement F, Canal C, Ricard A: Biological decontamination using high and reduced pressure nitrogen afterglows. Plasma Process Polym 2012;9:576-584.
37.
Percival SL, Hill KE, Williams DW, Hooper SJ, Thomas DW, Costerton JW: A review of the scientific evidence for biofilms in wounds. Wound Repair Regen 2012;20:647-657.
38.
Percival SL, Emanuel C, Cutting KF, Williams DW: Microbiology of the skin and the role of biofilms in infection. Int Wound J 2012;9:14-32.
39.
Høiby N, Ciofu O, Johansen HK, Song Z, Moser C, Jensen PO, Molin S, Givskov M, Tolker-Nielsen T, Bjanrsholt T: The clinical impact of bacterial biofilms. Int J Oral Sci 2011;3:55-65.
40.
Bayliss DL, Walsh JL, Iza F, Shama G, Holah J, Kong MG: Complex responses of microorganisms as a community to a flowing atmospheric plasma. Plasma Process Polym 2012;9:597-611.
41.
Singh MK, Ogino A, Nagatsu M: Inactivation factors of spore-forming bacteria using low-pressure microwave plasmas in an N2 and O2 gas mixture. New J Phys 2009;11:115027.
42.
Morfill GE, Shimizu T, Steffes B, Schmidt HU: Nosocomial infections - a new approach towards preventive medicine using plasmas. New J Phys 2009;11:115019.
43.
Klis FM, de Koster CG, Brul S: A mass spectrometric view of the fungal wall proteome. Future Microbiol 2011;6:941-951.
44.
Kogan G, Pajtinka M, Babincova M, Miadokova E, Rauko P, Slamenova D, Korolenko TA: Yeast cell wall polysaccharides as antioxidants and antimutagens: can they fight cancer? Neoplasma 2008;55:387-393.
45.
Hwang I, Lee J, Lee DG: Indole-3-carbinol generates reactive oxygen species and induces apoptosis. Biol Pharm Bull 2011;34:1602-1608.
46.
Repine JE, Fox RB, Berger EM: Hydrogen peroxide kills Staphylococcus aureus by reacting with Staphylococcal iron to form hydroxyl radical. J Biol Chem 1981;256:7094-7096.
47.
Hübner NO, Matthes R, Koban IU, Rändler C, Müller G, Bender C, Kindel E, Kocher T, Kramer A: Efficacy of chlorhexidine, polyhexanide and tissue-tolerable plasma against Pseudomonas aeruginosa biofilms grown on polystyrene and silicone materials. Skin Pharmacol Physiol 2010;23:28-34.
48.
Shimizo T, Nosenko T, Morfill GE, Sato T, Schmidt HU, Urayama T: Characterization of low-temperature microwave plasma treatment with and without UV light for disinfection. Plasma Process Polym 2010;7:288-293.
49.
Sarette JP, Cousty S, Clement F, Canal C, Ricard A: Biological decontamination using high and reduced pressure nitrogen afterglows. Plasma Process Polym 2012;9:576-584.
50.
Oehmingen K, Hähnel M, Brandenburg R, Wilke C, Weltmann KD, von Woedtke T: The role of acidification for antimicrobial activity of atmospheric pressure plasma in liquids. Plasma Process Polym 2010;7:250-257.
51.
Dissemond J, Witthoff M, Brauns TC, Haberer D, Goos M: pH-Wert des Milieus chronischer Wunden. Hautarzt 2003;54:959-965.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.